Delivery Order SPE2DB25D3504-SPE2DB25FVTSS
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,844.25 firm fixed-price delivery order is for the supply of Lamotrigine ER 300 mg tablets, a prescription anticonvulsant medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Lamotrigine ER 300 mg tablets to the U.S. government. The $1,004.29 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), under a broader Indefinite Delivery Contract (IDC) valued up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB23FRYZ1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,876.33 Firm Fixed Price contract is for the delivery of Lamotrigine ER 300 mg tablets, a pharmaceutical product, to support military and veterans' healthcare programs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,843.10, is for the delivery of Lamotrigine ER 300 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,671.47, is for the delivery of Lamotrigine ER 100 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
This federal contract award, valued at $3,128.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lamotrigine ER 250 mg tablets, a pharmaceutical product used to treat certain mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ODT 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,125.81 and a period of performance through January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,896.92 and runs through April 30, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a for-profit organization registered in the System for Award Management (SAM.gov). The contract is a delivery order with a firm-fixed price of $1,304.18 and an ultimate completion date of...